06:56 AM EDT, 05/04/2026 (MT Newswires) -- Cabaletta Bio ( CABA ) said Monday it priced an underwritten offering of 51.7 million shares at $2.90 apiece, raising $150 million in gross proceeds.
The drugmaker said proceeds from the offering, expected to close Tuesday, will support development of its lead candidate rese-cel and broader clinical pipeline.